Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Optase
Generic name: GLYCERIN
Manufacturer: Scope Health Inc
Product type: HUMAN OTC DRUG
SPL set ID: 376e0289-28e9-e87f-e063-6294a90a3b04
SPL ID: 49961a0b-9956-de48-e063-6394a90a7c53
Version: 2
Effective date: 2026-01-30
Source export date: 2026-09-28
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:17:18

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M018	openfda.application_number
brand name		Optase	openfda.brand_name
generic name		GLYCERIN	openfda.generic_name
manufacturer name		Scope Health Inc	openfda.manufacturer_name
ndc	package	72972-008-01	openfda.package_ndc
ndc	product	72972-008	openfda.product_ndc
ndc11	package	72972000801	derived:openfda.package_ndc
spl id		49961a0b-9956-de48-e063-6394a90a7c53	id
spl set id		376e0289-28e9-e87f-e063-6294a90a3b04	set_id
unii		PDC6A3C0OX	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning ■ For external use only. ■ If solution changes color or becomes cloudy, do not use. ■ To avoid contamination, do not touch tip of container to any surface. Replace cap after using. Stop use and ask doctor if ■ You feel eye pain. ■ Changes in vision occur. ■ Redness or irritation of the eye lasts. ■ Condition worsens or lasts more than 72 hours.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.